Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 26, 2024World Journal of CardiologyOpen Access

Sodium-dependent glucose transporter 2 inhibitors effects on myocardial function in patients with type 2 diabetes and asymptomatic heart failure

View Full Paper
Ask AI
Bookmark
Share

Authors

PRPetra Grubić RotkvićLRLuka RotkvićAČAna Đuzel Čokljat

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rotkvić et al. (2024) studied this question.

synapsesocial.com/papers/68e5adc8b6db64358754740chttps://doi.org/10.4330/wjc.v16.i8.448
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Effect of sodium-glucose cotransporter-2 inhibitors on blood pressure in patients with heart failure: a systematic review and meta-analysis2022 · 52 citations
  2. 2Effect of empagliflozin on left ventricular contractility and peak oxygen uptake in subjects with type 2 diabetes without heart disease: results of the EMPA-HEART trial2022 · 45 citations
  3. 3Empagliflozin in Heart Failure with a Preserved Ejection Fraction2021 · 4,865 citations
  4. 4Fenofibrate improves endothelial function and plasma myeloperoxidase in patients with type 2 diabetes mellitus: an open-label interventional study2014 · 12 citations
  5. 5Markers of Inflammation and Cardiovascular Disease2003 · 6,426 citations